Rapid diagnostic testing procedures for lysosomal storage disorders: α-glucosidase and β-galactosidase assays on dried blood spots

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 38-41

  Gasparotto, Nicoletta ^a   Tomanin, Rosella ^a   Frigo, Anna Chiara ^a   Niizawa, Gabriela ^b   Pasquini, Elisabetta ^c   Blanco, Mariana ^d   Donati, Maria Alice ^c   Keutzer, Joan ^e   Zacchello, Franco ^a   Scarpa, Maurizio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Fundación para el Estudio de Las Enfermedades Neurometabó licas FESEN Laboratorio de Neuroquímica Dr N A Chamoles   (Argentina)

^e GENZYME CORPORATION   (United States)

Author keywords

glucosidase; galactosidase; Dried blood spot; Enzyme assay; Lysosomal storage disorders

Indexed keywords

ALPHA GLUCOSIDASE; BETA GLUCOSIDASE;

ADULT; ARTICLE; BLOOD; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FEMALE; FILTER; HUMAN; LYSOSOME STORAGE DISEASE; MALE; MICROARRAY ANALYSIS; MONITORING; NEWBORN; PRIORITY JOURNAL; RELIABILITY; STATISTICAL SIGNIFICANCE; TEMPERATURE DEPENDENCE;

ADULT; ALPHA-GLUCOSIDASES; BETA-GALACTOSIDASE; BLOOD CHEMICAL ANALYSIS; HUMANS; INFANT, NEWBORN; LYSOSOMAL STORAGE DISEASES; MIDDLE AGED;

ADONIS ANNUA;

EID: 60649094505     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.12.006     Document Type: Article

References (21)

1. Hirschhorn R., and Reuser A. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill, New York, New York 3389-3420
2. Ausems M.G., Verbiest J., Hermans M.P., et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 7 (1999) 713-716
3. Martiniuk F., Chen A., Mack A., et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 79 (1998) 69-72
4. Van Hove J.L., Yang H.W., Wu J.Y., Brady R.O., and Chen Y.T. High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. Proc Natl Acad Sci U S A 93 (1996) 65-70
5. Meikle P.J., and Hopwood J.J. Lysosomal storage disorders: emerging therapeutic options require early diagnosis. Eur J Pediatr 162 Suppl 1 (2003) S34-37
6. Suzuki Y. Beta-galactosidase deficiency: an approach to chaperone therapy. J Inherit Metab Dis 29 (2006) 471-476
7. Okumiya T., Sakuraba H., Kase R., and Sugiura T. Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease. Mol Genet Metab 78 (2003) 51-58
8. Brunetti-Pierri N., and Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab 94 (2008) 391-396
9. Caciotti A., Donati M.A., d'Azzo A., et al. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient. Eur J Paediatr Neurol (2008)
10. Meikle P.J., Ranieri E., Simonsen H., et al. Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy. Pediatrics 114 (2004) 909-916
11. Pagliardini S., and Spada M. A simple and rapid approach for screening lysosomal storage disorders. J Inherit Metab Dis 26 (2003)
12. Chamoles N.A., Niizawa G., Blanco M., Gaggioli D., and Casentini C. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 347 (2004) 97-102
13. Zhang H., Kallwass H., Young S.P., et al. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med 8 (2006) 302-306
14. Chamoles N.A., Blanco M.B., Gaggioli D., and Casentini C. Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper. Clin Chem 47 (2001) 2098-2102
15. Kallwass H., Carr C., Gerrein J., et al. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots. Mol Genet Metab 90 (2007) 449-452
16. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res 8 (1999) 135-160
17. Chien Y.H., Chiang S.C., Zhang X.K., et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics 122 (2008) e39-45
18. Gelb M.H., Turecek F., Scott C.R., and Chamoles N.A. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29 (2006) 397-404
19. Wang D., Wood T., Sadilek M., Scott C.R., Turecek F., and Gelb M.H. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease). Clin Chem 53 (2007) 137-140
20. Hayes I.M., Collins V., Sahhar M., Wraith J.E., and Delatycki M.B. Newborn screening for mucopolysaccharidoses: opinions of patients and their families. Clin Genet 71 (2007) 446-450
21. Spada M., Pagliardini S., Yasuda M., et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79 (2006) 31-40